Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk: an observational study

Transcripts of human endogenous retrovirus K are expressed in most breast cancers (BCs). Yellow fever vaccine 17D (YFV) expresses a protein with a closely homologous epitope. Cross-reactive immunity could hypothetically inhibit BC growth at least in women aged around 50 years at diagnosis, in whom t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastrangelo, Giuseppe, Pavanello, Sofia, Fadda, Emanuela, Buja, Alessandra, Fedeli, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Research Papers: Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012044/
https://www.ncbi.nlm.nih.gov/pubmed/27870643
http://dx.doi.org/10.1097/CEJ.0000000000000333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012044/
https://www.ncbi.nlm.nih.gov/pubmed/27870643
http://dx.doi.org/10.1097/CEJ.0000000000000333

Ejemplares similares